BRIEF published on 12/13/2024 at 23:05, 1 year 6 months ago Relief Therapeutics va mettre fin à ses obligations de déclaration auprès de la SEC avec le dépôt du formulaire 15F OTCQB Bourse Suisse SIX THÉRAPEUTIQUE DE SECOURS Formulaire 15F Rapports De La SEC
PRESS RELEASE published on 12/13/2024 at 23:00, 1 year 6 months ago Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations Relief Therapeutics announces filing of Form 15F to terminate SEC reporting obligations, maintaining listing on SIX Swiss Exchange and U.S. over-the-counter market SIX Swiss Exchange Relief Therapeutics SEC Reporting Form 15F U.S. OTCQB
BRIEF published on 11/11/2024 at 07:05, 1 year 7 months ago Relief Therapeutics Reports Positive Outcomes in RLF-TD011 Trial for Epidermolysis Bullosa Relief Therapeutics RLF-TD011 Clinical Trial Results Epidermolysis Bullosa Microbiome Diversity
BRIEF published on 11/11/2024 at 07:05, 1 year 7 months ago Relief Therapeutics rapporte des résultats positifs dans l'essai RLF-TD011 pour l'épidermolyse bulleuse THÉRAPEUTIQUE DE SECOURS RLF-TD011 Résultats Des Essais Cliniques Epidermolyse Bulleuse Diversité Du Microbiome
PRESS RELEASE published on 11/11/2024 at 07:00, 1 year 7 months ago Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa Relief Therapeutics reports positive final results from RLF-TD011 clinical trial for Epidermolysis Bullosa, showing effective wound healing and microbiome diversity improvements Clinical Trial Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Microbiome Diversity
BRIEF published on 11/04/2024 at 07:05, 1 year 8 months ago Relief Therapeutics and Renexxion Consider Reverse Merger Biotechnology Shareholder Value Healthcare Reverse Merger Gastrointestinal Disorders
BRIEF published on 11/04/2024 at 07:05, 1 year 8 months ago Relief Therapeutics et Renexxion envisagent une fusion inversée Biotechnologie Valeur Actionnariale Soins De Santé Fusion Inversée Troubles Gastro-intestinaux
PRESS RELEASE published on 11/04/2024 at 07:00, 1 year 8 months ago Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger Relief Therapeutics signs non-binding letter of intent with Renexxion for reverse merger, aiming to create a combined entity with an expanded therapeutic pipeline Biopharmaceutical Relief Therapeutics Therapeutic Pipeline Reverse Merger Renexxion
BRIEF published on 10/29/2024 at 07:05, 1 year 8 months ago Relief Therapeutics Highlights PKU GOLIKE Findings Patient Engagement Relief Therapeutics PKU GOLIKE Phenylketonuria Amino Acid Absorption
BRIEF published on 10/29/2024 at 07:05, 1 year 8 months ago Relief Therapeutics met en avant les résultats de l'étude PKU GOLIKE PKU GOLIKE THÉRAPEUTIQUE DE SECOURS Engagement Des Patients Phénylcétonurie Absorption Des Acides Aminés
Published on 07/09/2026 at 10:00, 1 hour 38 minutes ago GMV Minerals Announces Completion of 16 Diamond Drill Holes on the Mexican Hat Gold Project in SE Arizona - Drill Assays Pending with ~1500 Samples Submitted to Date
Published on 07/09/2026 at 09:35, 2 hours 3 minutes ago Haier Europe Appoints Stagwell (STGW) as Creative Agency for the Haier Brand, Following Ingenuity+ Pitch Process
Published on 07/09/2026 at 09:01, 2 hours 37 minutes ago Apex Critical Metals Announces Listing of Common Shares on Euronext Access Paris
Published on 07/09/2026 at 08:00, 3 hours 38 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 07/09/2026 at 00:00, 11 hours 38 minutes ago Alset AI Announces Closing of Shares for Debt Transaction
Published on 07/09/2026 at 11:05, 33 minutes ago Bringing Fans Closer to the Game: Hisense Enhances FIFA World Cup 2026™ Viewing Through Display Innovation
Published on 07/09/2026 at 11:05, 33 minutes ago EQS-Adhoc: SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO
Published on 07/09/2026 at 11:00, 38 minutes ago ABB Ltd: ABB share buybacks - July 2, 2026 - July 8, 2026
Published on 07/09/2026 at 11:00, 38 minutes ago Board and Advisory Appointments Support Global Expansion
Published on 07/09/2026 at 10:37, 1 hour ago EQS-Adhoc: Covestro AG: EBITDA forecast for fiscal year 2026 raised
Published on 07/09/2026 at 07:30, 4 hours 8 minutes ago Half-year liquidity contract statement June 30, 2026
Published on 07/09/2026 at 07:30, 4 hours 8 minutes ago Half-year liquidity contract statement June 30, 2026
Published on 07/08/2026 at 20:00, 15 hours 38 minutes ago ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
